Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Evaluation and Treatment of Patients with Lung Disease not Participating in Research Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on Evaluation and Treatment of Patients with Lung Disease not Participating in Research conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Evaluation and Treatment of Patients with Lung Disease not Participating in Research Clinical research trials and Evaluation and Treatment of Patients with Lung Disease not Participating in Research medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including Evaluation and Treatment of Patients with Lung Disease not Participating in Research. Evaluation and Treatment of Patients with Lung Disease not Participating in Research Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Evaluation and Treatment of Patients with Lung Disease not Participating in Research clinical trial. Participants oftentimes recieve the finest healthcare available for their Evaluation and Treatment of Patients with Lung Disease not Participating in Research condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "E" Clinical Trials Conditions > Evaluation and Treatment of Patients with Lung Disease not Participating in Research

Evaluation and Treatment of Patients with Lung Disease not Participating in Research



Evaluation and Treatment of Patients with Lung Disease not Participating in Research

For Condition: Lung Disease
Status: Recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: This study was developed in order for the professional-staff at the Pulmonary-Critical Care Medical Branch (PCCMB) of the National Heart, Lung, and Blood Institute to maintain their skills and increase their understanding of lung diseases. The study will permit PCCMB staff members to evaluate and treat patients with lung disease who do not meet the criteria for other research studies.
Details: The professional staff in the Pulmonary-Critical Care Medicine Branch (PCCMB) needs to maintain their clinical skills and to enhance their clinical knowledge. The purpose of this protocol is to permit PCCMB staff to evaluate and treat patients with pulmonary disease who do not meet the criteria for existing research protocols.
Eligibility:
Study Type:
  Interventional, Training
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Patients 10 through 65 years of age with signs or symptoms of pulmonary disease of medical interest to the professional staff of PCCMB will be eligible for participation in this protocol. Only standard diagnostic procedures and conventional therapy will be performed. Patients will not be subjected to any research procedures. EXCLUSION CRITERIA: Patients without symptoms of pulmonary disease will be excluded from this protocol.
Total Enrollment: 9999

Location and Contact Information:

National Heart, Lung and Blood Institute (NHLBI) *Recruiting*
Bethesda,  Maryland,  20892
United States
Recruiting Patient  and Public Liaison Office 1-800-411-1222


Additional Information:
Study ID Numbers:
  970061;  97-H-0061
Study Start Date: January 7, 1997
Record last reviewed: December 8, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001621

Other Lung Disease Studies:
1. Evaluation and Treatment of Patients with Lung Disease not Participating in Research

2. Cardiovascular Vulnerability to Particulate Exposure

3. The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)

4. Evaluation of the Causes and Disease Processes of Chronic Lung Disease

5. Benefits and Risks of Newborn Screening for Cystic Fibrosis

Related Studies:

Other Lung Disease Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials

Evaluation and Treatment of Patients with Lung Disease not Participating in Research

Modify your Search

  Other Lung Disease Clinical Trials
  Other Maryland Clinical Trials
  Other Bethesda Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103